Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Illumina    ILMN

ILLUMINA (ILMN)
Mes dernières consult.
Most popular
Rapport
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
10/13/2017 10/16/2017 10/17/2017 10/18/2017 10/19/2017 Date
206.92(c) 206.23(c) 206.48(c) 205.62(c) 205.18 Last
422 227 485 564 545 410 470 677 432 670 Volume
-0.63% -0.33% +0.12% -0.42% -0.21% Change
More quotes
Financials ($)
Sales 2017 2 684 M
EBIT 2017 645 M
Net income 2017 792 M
Finance 2017 821 M
Yield 2017 -
Sales 2018 3 054 M
EBIT 2018 808 M
Net income 2018 605 M
Finance 2018 1 174 M
Yield 2018 -
P/E ratio 2017 38,17
P/E ratio 2018 50,37
EV / Sales2017 10,9x
EV / Sales2018 9,46x
Capitalization 30 082 M
More Financials
Company
Illumina, Inc. develops, manufactures and markets integrated systems for the analysis of genetic variation and function.It provides sequencing and array-based solutions for genetic analysis in addition to selling products, it provide genotyping, NIPT and whole-genome sequencing services.The company... 
More about the company
Surperformance© ratings of Illumina
Trading Rating : Investor Rating :
More Ratings
Latest news on ILLUMINA
03:15pILLUMINA, INC. : quaterly earnings release
10/16 ILLUMINA : Releases NovaSeq S4 Flow Cell and NovaSeq Xp Workflow
10/12 ILLUMINA : Patent Issued for Fluidic System for Reagent Delivery to a Flow Cell ..
10/11 ILLUMINA : purchase of the Illumina Care Advantage Plan to perform routine maint..
10/10 ILLUMINA : to Announce Third Quarter 2017 Financial Results on Tuesday, October ..
10/06 ILLUMINA : D-Notice of Intent to Sole Source - Subscription License Annual Renew..
09/27 ILLUMINA : Annual Service Agreement on Illumina Equiment
09/26 ILLUMINA : MILITARY $159,208 Federal Contract Awarded to Illumina
09/22 ILLUMINA : $19.5 Million Federal Contract Awarded to Illumina
09/21 ILLUMINA : BlueMountain Capital Management LLC Acquires New Position in Illumina..
More news
Sector news : Advanced Medical Equipment & Technology - NEC
10/17 European shares slip from highs as results, commodities weigh
10/16 Kobe Steel scandal latest to expose 'Made-in-Japan' fault-lines
10/11DJROYAL PHILIPS : Philips to Suspend Production of External Defibrillators at US F..
10/09 LafargeHolcim poaches Essilor's finance chief
10/09DJBOSTON SCIENTIFIC : Health-care Firms Used Radio, Social Media to Find Missing W..
More sector news : Advanced Medical Equipment & Technology - NEC
4-Traders Strategies on ILLUMINA 
ILLUMINA - 10/06
There is still some upside potential
BUY
ILLUMINA - 06/29
The stock is approaching a major resistance level
BUY
More Strategies
Latest Tweets
10/18Sentry Investment Management LLC Holds Stake in Illumina, Inc. $ILMN  
10/17Get the latest news and updates for $CNI $ISRG $ILMN $NMHLY $FNERF automatica.. 
10/17Jay Flatley and John Martin to be Named Recipients of Life Sciences Leadershi..
1
10/17This strikes me as an excellent use of a corp VC - to encourage entreps to fi..
5
10/16Good news for all the genomics start-ups -- def in Illumina's interest to fun..
11
More tweets
Qtime:125
News from SeekingAlpha
10/17 PacBio Is A DNA Sequencing Standout
10/16 YOUR DAILY PHARMA SCOOP : ACRX Second Chance, AERI Rhopressa Success, Aratana EN..
10/11 Seeking Alpha? Here's Alpha
10/11 Gene Sequencing, The Driver Of Personalized Medicine
10/10 YOUR DAILY PHARMA SCOOP : MannKind Is A Trade Not An Investment; AstraZeneca's I..
Chart ILLUMINA
Duration : Period :
Illumina Technical Analysis Chart | ILMN | US4523271090 | 4-Traders
Technical analysis trends ILLUMINA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 18
Average target price 193 $
Spread / Average Target -6,1%
EPS Revisions
Managers
NameTitle
Francis A. deSouza President, Chief Executive Officer & Director
Jay T. Flatley Executive Chairman
Ostadan Omead Executive VP-Operations, Products & Strategy
Sam A. Samad Chief Financial Officer & Senior Vice President
Mostafa Ronaghi Chief Technology Officer & Senior Vice President
Sector and Competitors
1st jan.Capitalization (M$)
ILLUMINA60.59%30 082
THERMO FISHER SCIENTIFIC INC.34.10%75 478
DANAHER10.55%59 778
BOSTON SCIENTIFIC CORPORATION36.48%40 505
INTUITIVE SURGICAL67.64%39 496
ROYAL PHILIPS20.07%38 649